Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. [electronic resource]
Producer: 20030514Description: 953-9 p. digitalISSN:- 0041-1337
- Acute Disease
- Animals
- Aurintricarboxylic Acid -- pharmacology
- Blood Physiological Phenomena
- Blood Platelets -- drug effects
- Complement Activation -- drug effects
- Dipeptides -- pharmacology
- Drug Synergism
- Graft Rejection -- metabolism
- Graft Survival
- Hematocrit
- Histamine -- blood
- Humans
- Lung -- drug effects
- Lung Transplantation
- Platelet Glycoprotein GPIIb-IIIa Complex -- metabolism
- Platelet Glycoprotein GPIb-IX Complex -- metabolism
- Platelet Membrane Glycoproteins
- Swine
- Thrombin -- biosynthesis
- Thromboxane B2 -- metabolism
- Transplantation, Heterologous
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.